1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancer

Technology appraisal guidance [TA812] Published: 03 August 2022

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

  • Draft matrix post referral PDF 185 KB 11 March 2021  
  • Draft scope post referral PDF 276 KB 11 March 2021  

This page was last updated: 11 March 2021